Question: Selected income statement and balance sheet data from Merck & Co for Year 9 are reproduced below: Merck & Co, Inc. Year 9 Selected Financial
Selected income statement and balance sheet data from Merck & Co for Year 9 are reproduced below:
| Merck & Co, Inc. | |
| Year 9 Selected Financial Data (millions) | |
| Income statement data: | |
| Sales Revenue | 7120 |
| Depreciation | 230 |
| Interest Expense | 10 |
| Pretax Income | 2550 |
| Income Taxes | 900 |
| Net Income | 1650 |
| Balance Sheet Data: | |
| Current Assets | 4850 |
| Fixed Assets, Net | 2400 |
| Total Assets | 7250 |
| Current Liabilities | 3290 |
| Long-term Debt | 100 |
| Shareholders' Equity | 3860 |
| Total Liabilities & Shareholders' Equity | 7250 |
Required:
- Calculate return on common equity for Year 9 using year-end amounts and assuming no preferred dividends.
- Disaggregate Merck's ROA. Comment on Merck's use of leverage. Assume all assets and current liabilities are operating and a 35% tax rate.
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
